NCT01600365View on ClinicalTrials.gov

Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus

PHASE3UnknownINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
ConjunctivitisAdenovirus.
Interventions
DRUG

Ophthalmic gel (placebo)

Ophthalmic gel (placebo): applied in affected eye 4 times daily for 10 days

DRUG

Ganciclovir

Ophthalmic gel ganciclovir 0,3%: applied in affected eye 4 times daily for 10 days

Sponsors
All Listed Sponsors
lead

Adapt Produtos Oftalmológicos Ltda.

INDUSTRY

NCT01600365 - Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus | Biotech Hunter | Biotech Hunter